4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000231
EVP CLO & General Counsel sold 21,000 shares at $64.56 ($1,355,661)
- EVP CLO & General Counsel acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Option exercise 10b5-1 | +20,000 | $60.89 | $1,217,800 | 77,130 | D: show line 1 in the form |
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Sale 10b5-1 | −20,000 | $64.56 | $1,291,106 | 57,130 | D: show line 2 in the form |
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Option exercise 10b5-1 | +1,000 | $56.78 | $56,780 | 58,130 | D: show line 3 in the form |
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Sale 10b5-1 | −1,000 | $64.56 | $64,555 | 57,130 | D: show line 4 in the form |
| Open-market sales · 21,000 sh · avg $64.56 · $1,355,661 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,000 | 57,203 | D: show line 5 in the form | |||||
| O'NEIL PATRICK R. EVP CLO & General Counsel | 2025-09-09 | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −20,000 | 34,461 | D: show line 6 in the form |
Loading xslF345X05/edgardoc.xml…